4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the FDA since Jan. 12.

Advertisement

1. Firvanq is a vancomycin hydrochloride oral solution used to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation.

2. Lutathera is a radioactive drug that treats gastroenteropancreatic neuroendocrine tumors.

3. Bivalirudin is an anticoagulant intended for patients undergoing percutaneous coronary intervention.

4. Avycaz may now be used to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

More articles on supply chain:
10 most-read supply chain stories in January
Hospitals face shortage of sterile water for injections: 5 things to know
FDA approves record number of personalized medicines in 2017: 4 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.